An accredited Developing
Stage business incubator
uk inspire Send this page | Bookmark | Print |

Business incubator for biotech and medtech startups


Success stories

At Cardiff Medicentre we work hard to help set biotech and medtech startups on the path to success.

Our incubation facility has been home to businesses which have gone on to take up their own stand-alone facilities, raise substantial amounts of venture capital or to be acquired by larger companies.

Here are some examples:

BioDynamics Research

A leading, specialist provider of metabolism, bioanalytical and radiochemistry services to the worldwide pharmaceutical and biotechnology industries.

The company was acquired by Quotient BioResearch in February 2008.

Further expansion for Quotient BioResearch in drug development services.

Cardiff Bioanalytical Services

A leading provider of External Quality Assessment schemes for clinical and forensic toxicology and therapeutic drug monitoring.

In November 2010, Cardiff Bioanalytical Services was acquired by LGC.

LGC Standards extends portfolio with Cardiff Bioanalytical Services acquisition.

Cardiff Research Consortium

Cardiff Research Consortium provided analysis and consultancy services for pharmaceutical companies to determine the potential cost benefit of a particular drug regime and for support to the drugs trial process using an extensive outcomes research database.

In July 2006, Inflexion Private Equity led the acquisition of Cardiff Research Consortium on behalf of its portfolio company Healthcare Knowledge International, which consisted of CHKS, its UK division, and Iasist in Spain.

Inflexion leads buy-out of CRC Ltd.

Outsourcing giant Capita Group then purchased Cardiff Research Consortium in February 2009 as part of its £11.6m acquisition of CHKS.

Capita acquires healthcare informatics specialist CHKS Ltd.

onExamination Ltd

onExamination was formed by two doctors from Cardiff University who saw the potential of the internet to help doctors prepare for examinations.

The company was acquired by BMJ Group in December 2007.

BMJ Group announces acquisition of onExamination.

Q Chip

Q Chip is a biopharmaceutical company developing sustained release injectable depot formulations.

In May 2011, the company completed a $6 million funding round and signed an agreement with a leading international speciality pharmaceutical company in November 2011.

$6m to expand drug formulation portfolio and establish European manufacturing facility.

Q Chip Announces Agreement with Leading International Speciality Pharma.

Synexus Clinical Research

Synexus is the largest clinical trials management and patient recruitment organisation in Europe.  When establishing its presence in Wales, the company leased space at Cardiff Medicentre. In late 2002, the company graduated to larger, bespoke premises within Cardiff.

In 2005, Synexus listed on AIM, the London Stock Exchange’s international market for smaller growing companies. In 2007, the company was taken private by Lyceum Capital at a valuation of £18 million.

Lyceum Capital announces recommended offer to take Synexus private.


TrichoTech focused on detecting drugs of abuse, principally through testing hair samples.

The company was acquired by Concateno plc for £11.25 million in January 2007.

Drug testing firm sold for £11.5m.


Indoor Biotechnologiesy has become the latest business to graduate from life sciences incubator Cardiff Medicentre.

Indoor Biotechnologies launched in 2012 as a specialist life sciences company that helps detect the causes of, and offers solutions to, various allergens including those from pollen, food, animals and mites.Dr James Hindley, executive director of Indoor said: “Our time at Cardiff Medicentre has put us in the best possible position to enter phase two of our development. The support we have had from the Medicentre team and their contacts has enabled us to establish a strong presence within Europe and beyond.

how to apply

Follow us

  • RSS Feed